Adults 18 years and older may qualify for a study evaluating investigational treatment options for diabetic peripheral neuropathic pain (DPNP), also called diabetic nerve pain in the legs and feet. Participants in this study must have diabetes and symptoms of painful diabetic neuropathy.
Researchers are studying investigational treatments in a chronic pain master protocol to better understand whether these treatments may help reduce pain severity and improve daily functioning in adults with DPNP. Pain and physical functioning in this study are measured using the Brief Pain Inventory–Short Form Modified (BPI-SFM).
You may be able to join if you:
-Are 18 years of age or older.
-Have a history and current diagnosis of type 1 or type 2 diabetes mellitus.
-Have diabetic peripheral neuropathy affecting the lower extremities in a symmetrical pattern for at least 6 months.
-Meet neuropathy screening criteria based on the Michigan Neuropathy Screening Instrument.
Adults 18 years and older may qualify for a study evaluating investigational treatment options for diabetic peripheral neuropathic pain (DPNP), […]
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], […]
Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating […]
Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating […]
Adults who are overweight or obese and currently using semaglutide (Ozempic®/Wegovy®) or tirzepatide (Mounjaro®/Zepbound®) may qualify for a research study […]
Adults 18 and older with obstructive sleep apnea (OSA) and overweight or obesity may qualify for a clinical study evaluating […]
